Billable ICD-10-CM code, FY2026. Acts as a Complication or Comorbidity (CC) as a secondary diagnosis.
Applicable to
Lupus anticoagulant
Presence of systemic lupus erythematosus [SLE] inhibitor
Excludes1 (never code together)
lupus anticoagulant (LAC) finding without diagnosis (R76.0)
Excludes2 (not included here)
anticardiolipin syndrome (D68.61)
antiphospholipid syndrome (D68.61)
lupus anticoagulant (LAC) with hemorrhagic disorder (D68.312)
Applies from D68 Other coagulation defects
Excludes1 (never code together)
abnormal coagulation profile NOS (R79.1)
Excludes2 (not included here)
coagulation defects complicating abortion or ectopic or molar pregnancy (O00-O07, O08.1)
coagulation defects complicating pregnancy, childbirth and the puerperium (O45.0, O46.0, O67.0, O72.3)
Applies from D68.6 Other thrombophilia
Applicable to
Other hypercoagulable states
Excludes1 (never code together)
diffuse or disseminated intravascular coagulation [DIC] (D65)
heparin induced thrombocytopenia (HIT) (D75.82-)
hyperhomocysteinemia (E72.11)
Risk adjustment (HCC)
CMS-HCC V22: HCC 48 — Coagulation Defects and Other Specified Hematological Disorders
ESRD V24: HCC 48
MS-DRG index
Defines the logic of DRG(s) 814-816 in MDC 16.
Approximate ICD-9-CM (GEMs)
289.81 Primary hypercoagulable state (approximate)
Code annotations containing back-references to D68.62
Back-references to D68.62
Type 2 Excludes: D68.312 Antiphospholipid antibody with hemorrhagic disorder ("lupus anticoagulant (LAC) with hypercoagulable state (D68.62)")
Type 2 Excludes: D68.312 Antiphospholipid antibody with hemorrhagic disorder ("systemic lupus erythematosus [SLE] inhibitor with hypercoagulable state (D68.62)")
Type 1 Excludes: D68.5 Primary thrombophilia ("lupus anticoagulant (D68.62)")
Type 2 Excludes: D68.61 Antiphospholipid syndrome ("lupus anticoagulant syndrome (D68.62)")
Back-references to D68
Type 1 Excludes: R79.1 Abnormal coagulation profile ("coagulation defects (D68.-)")